{"disease":{"id":"hiv-1-infection-in-combination-with-other-antiretroviral-agents-in-pediatric-patients-4-weeks-of-age-and-older-and-weighing-at-least-3-kg-in-the-absence-of-antiretroviral-treatment-failure-and-with-no-prior-antiretroviral-therapy-and-with-viral-load-100-000-copies-ml-or-less-and-with-cd4-percentage-25-or-greater-and-with-no-prior-antiretroviral-therapy.md","name":"hiv 1 infection in combination with other antiretroviral agents in pediatric patients 4 weeks of age and older and weighing at least 3 kg in the absence of antiretroviral treatment failure and with no prior antiretroviral therapy and with viral load 100 000 copies ml or less and with cd4 percentage 25 or greater and with no prior antiretroviral therapy.md"},"drugs":{"marketed":[],"pipeline":[],"offLabel":[],"totalMarketed":0,"totalPipeline":0},"trials":{"data":[],"total":0},"guidelines":[],"source":"Drug Landscape verified database"}